New Risk • Oct 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 10% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (AU$2.1m revenue, or US$1.4m). Market cap is less than US$100m (AU$105.8m market cap, or US$69.5m). Tillkännagivande • Sep 19
Archer Materials Limited, Annual General Meeting, Nov 20, 2025 Archer Materials Limited, Annual General Meeting, Nov 20, 2025. New Risk • Dec 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 28% per year over the past 5 years. Minor Risks Revenue is less than US$5m (AU$2.1m revenue, or US$1.3m). Market cap is less than US$100m (AU$117.2m market cap, or US$73.3m). Board Change • Nov 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Non-Executive Director Bernadette Harkin was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Oct 18
Archer Materials Limited, Annual General Meeting, Nov 20, 2024 Archer Materials Limited, Annual General Meeting, Nov 20, 2024. Location: stone & chalk sydney scaleup hub, level 2, 477 pitt street, haymarket, 2000., Australia New Risk • Sep 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 28% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Revenue is less than US$5m (AU$2.1m revenue, or US$1.5m). Market cap is less than US$100m (AU$57.3m market cap, or US$39.6m). Tillkännagivande • Jul 13
Mohammad Choucair to Step Down as Chief Executive Officer of Archer Materials Limited in January 2025 Archer Materials Limited announced the departure of Dr. Mohammad Choucair as Chief Executive Officer ("CEO"). Mohammad will step down from the CEO role in January 2025 to ensure a smooth transition and handover. Mohammad retires from the Company for personal reasons. New Risk • Apr 10
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Revenue is less than US$5m (AU$1.8m revenue, or US$1.2m). Market cap is less than US$100m (AU$128.7m market cap, or US$85.2m). Tillkännagivande • Mar 15
Archer Materials Limited Designs Miniaturised Version of Biochip Biochip Graphene Field Effect Transistor Chip Archer Materials Limited has designed a miniaturised version of its Biochip graphene field effect transistor (“gFET”) chip for fabrication at a commercial foundry. The Archer Biochip contains a sensing region of which the gFET is the core component. Each gFET chip contains multiple gFETs, each of which is a transistor, which acts as a sensor. Archer has miniaturised the total chip size by redesigning the layout of the circuits creating these gFET transistors. The new miniaturised design has been sent to a foundry partner for a whole-wafer fabrication of reduced size gFET chips, which Archer intends to integrate with other parts of the Biochip technology. The new gFET chip design has been significantly reduced in size over earlier designs of 10mm x 10mm to 1.5mm x 1.5mm. It will be tested on a four-inch wafer which is expected to produce 1375 chips on it, compared to the 45 chips produced using earlier designs in previous four-inch wafer fabrication runs. The chip will be fabricated by Applied Nanolayers (“ANL”), based in the Netherlands, which has fabricated earlier designs of Archer’s gFETs (ASX ann. 14 September 2023). Independent to wafer runs at ANL, Archer has also sent gFET designs to a foundry in Spain for fabrication, with delivery anticipated within the first half of 2024 (ASX ann. 11 December 2023). Archer applies the ‘fabless’ chipmaker model by designing, researching, and developing its chips, while outsourcing manufacturing to specialised companies in the semiconductor supply chain. This includes the creation of a new miniaturised Biochip gFET chip design, sending the design for a whole wafer run in a commercial foundry, and deciding on the chip assembly and semiconductor device electronics packaging and related electrical testing. The wafer will be diced and assembled at Archer’s newly established outsourced semiconductor assembly and testing (“OSAT”) partner, AOI Electronics in Japan. The OSAT includes moulding, dicing, and lead frame design for this dedicated wafer assembly, and also device electronic shorting and related packaging testing. These new capabilities are key in advancing the Biochip development to interfacing and integration with miniaturised gFET chip sensor designs. Delivery of the packaged chips is anticipated in mid-2024. Tillkännagivande • Nov 02
Archer Materials Limited Demonstrates Multiplexing Readout for its Advanced Biochip Graphene Field Effect Transistor Device Archer Materials Limited has demonstrated multiplexing readout for its advanced Biochip graphene field effect transistor (gFET) device. Archer confirmed single-device multiplexing using four advanced gFETs as sensors, which were integrated into the Archer advanced Biochip platform that was announced on 14 September 2023. This is significant as Archer intends to apply its multiplexing capability in the Biochip to test for multiple diseases on a single chip at once. Archer designed and developed the new hardware and software systems to readout the signal from the four advanced gFET sensors at once on a single chip. This is a significant advance over the earlier generation of the Biochip system, which could only activate one-sensor-at-a-time. The new Biochip system with multiplexing capability also provides automated hands-free operation, as it integrates liquid handling automation and data acquisition. The software developed by Archer can display all single and time series measurements in real-time for the four gFET sensors simultaneously. Tillkännagivande • Oct 28
Archer Materials Limited, Annual General Meeting, Nov 29, 2023 Archer Materials Limited, Annual General Meeting, Nov 29, 2023, at 10:30 E. Australia Standard Time. Location: KPMG, Level 38, Tower Three, International Towers Sydney 300 Barangaroo Avenue Sydney New South Wales Australia Agenda: To consider he Remuneration Report for the year ended 30 June 2023; to consider Re-election of Bernadette Harkin as a Director; to consider Approval of Issues of Securities under the New Performance Rights Plan and Share Option Plan; to consider Modification of the Company's Constitution; to consider Approval of 10% additional placement capacity; to consider Renewal of proportional takeover provisions in the Constitution; and to consider other matters. New Risk • Aug 17
New major risk - Revenue size The company makes less than US$1m in revenue. Total revenue: AU$1.6m (US$1m) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 53% per year over the past 5 years. Revenue is less than US$1m (AU$1.6m revenue, or US$1m). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Market cap is less than US$100m (AU$130.0m market cap, or US$83.6m). Tillkännagivande • Aug 01
Archer Materials Limited Further Enhances Biochip gFET Design for Advanced Sensing and Send to Commercial Foundry Partner Archer Materials Limited has developed a next generation biochip fabrication to better detect and control disease samples on a single graphene field effect transistor ("gFET") design. The gFET design also has functional surfaces and components, for both the sensor and control of the biochip platform. There is also an integration of gFET design components that allow for the real-time fine tuning and control of the electronic properties of the graphene. This has the potential advantage of biosensors that are re-usable, leading to an extended device lifetime. In addition, Archer has improved its biochip system platform testing capabilities to develop a more accurate sensor. The upgraded automated testing platform conducts both control software and readout hardware with improved efficiency. The software is also progressing towards automated data analysis, so end users can extract high quality data. This new more complex gFET design complements the proof-of-concept biosensing gFET announced on 13 July 2023. The earlier design was submitted to a commercial foundry for a Multi-Project Wafer run, with the completed devices expected to be delivered by the end of 2023. The new advanced device designs which are the subject of this announcement have now been submitted to a foundry in the Netherlands for a whole wafer run (the previous 'simpler' design was submitted to a foundry in Germany for a Multi- Project Wafer ("MPW") run). An MPW is where Archer's device design is imprinted on a small area of a wafer with the designs of other companies on the same wafer. The new more complex gFet design will be fabricated all over one, stand-alone four-inch wafer. The new advanced gFET device design and whole wafer run in a commercial foundry is an example of how Archer is now moving towards a streamlined commercialization model that closely aligns to the 'fabless' model (i.e. Archer focuses on designing and developing its chips and outsources the manufacturing to specialized foundries). The new gFET device designs and related processes form the basis of intellectual property that is 100% owned by Archer. Tillkännagivande • Jul 14
Archer Materials Limited Transfers Biochip Graphene Sensor Technology Design to A Commercial Fab to Verify Scalability Archer Materials Limited has completed a proof of concept biosensing graphene transistor for use in its biochip, and submitted the technology design to a commercial foundry to verify scalability. The Archer-designed gFET sensing chips will be produced by a commercial foundry, with the aim of Archer validating its design to ensure appropriate scalability for the manufacturing process. Archer expects completed runs to arrive at the end of 2023. The runs will be evaluated to test which foundry and process are best suited to Archer's technology. Archer's design and process can then be scaled to manufacture complete wafers containing the graphene-based sensors for biochip integration in collaboration with a range of different commercial foundries. Archer has, in parallel, started discussions with potential global foundry partners for initial small production runs of its graphene chip designs to evaluate the reliability of the product. The latest development follows the recent announcement on 10 March 2023 in which the Company gained electronic control of the sensitivity of its incorporated gFET devices so it can better target biomolecules. This followed Archer's early-stage biochip prototype with an integrated system platform for biosensing announced to the market on 16 November 2022, after having developed a 'wettable' gFET announced on 24 October 2022. Recent Insider Transactions Derivative • Apr 01
Executive Chairman of the Board exercised options and sold AU$384k worth of stock On the 31st of March, Gregory English exercised options to acquire 881k shares at no cost and sold these for an average price of AU$0.44 per share. This trade did not impact their existing holding. Since June 2022, Gregory's direct individual holding has decreased from 3.53m shares to 1.91m. Company insiders have collectively sold AU$347k more than they bought, via options and on-market transactions in the last 12 months. Tillkännagivande • Nov 16
Archer Materials Limited Implements an Early-Stage Prototype of an Integrated Biochip Platform Archer Materials Limited informed shareholders that the Company has implemented an early-stage prototype of an integrated biochip platform with automated liquid sample handling and readout. The work is a major milestone towards Archer's biochip technology commercialisation. The company's biochip innovation aims to integrate graphene field effect transistors ("gFETs") into advanced fluidic systems to create miniaturised lab-on-a-chip device platforms for medical diagnostics. In particular, the integration of gFETs with on-chip fluidics to potentially enable multiplexing, i.e., the ability to parallelise the detection of multiple biologically relevant targets fluids, on a chip. The company has made significant technological progress over the last year that fundamentally link to the development of a prototype biochip technology system platform, recently designing and fabricating an operational liquid-gated gFET, i.e., a wettable transistor. For the first time, the company has now developed, built, and configured a method, device, and prototype operational system platform for lab-on-a-chip sensing of the electronic properties of biologically relevant fluid samples (Image 1). This is a major milestone towards commercialisation of Archer's biochip technology. Recent Insider Transactions Derivative • Nov 01
Executive Chairman of the Board exercised options to buy AU$315k worth of stock. On the 31st of October, Gregory English exercised 500.00k options at around AU$0.15, then sold 50.62k of them at AU$0.76 each and kept the remainder. Since December 2021, Gregory has owned 3.53m shares directly. Company insiders have collectively bought AU$37k more than they sold, via options and on-market transactions, in the last 12 months. Tillkännagivande • Oct 24
Wettable Graphene Transistor Built for Biochip Integration Archer Materials Limited has achieved a long-term biochip technology development goal to fabricate an operational liquid-gated graphene field effect transistor ("gFET"). Archer's biochip innovation aims to integrate gFETs into advanced microfluidic systems to create miniaturised lab-on-a-chip device platforms for medical diagnostics. In particular, the integration of gFETs with on-chip microfluidics to potentially enable multiplexing, i.e., the abilityto parallelise the detection of multiple biologically relevant targets in droplet-size liquid samples on a chip. gFETs offer an ultrasensitive approach to analyte detection over conventional electronic sensors used in current lab-on-a-chip devices. The gFET device is the sensing component that will be used for digitising biologically relevant signals, like those from target analytes of viruses or bacteria, and it is a foundational feature ofArcher's `lab-on-a-chip' biochip technology. Tillkännagivande • Oct 22
Archer Materials Limited, Annual General Meeting, Nov 23, 2022 Archer Materials Limited, Annual General Meeting, Nov 23, 2022, at 10:30 AUS Eastern Standard Time. Location: offices of Grant Thornton Australia Limited, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and consider the Financial Report, the Directors' Report and the Auditor's Report for the financial year ended 30 June 2022; to consider the adoption of Remuneration Report; to consider the re-election of Kenneth Williams as a Director; to consider the approval of Performance Rights Plan and Share Option Plan; and to consider the approval of 10% additional placement capacity. Tillkännagivande • Oct 10
Archer Materials Limited Uses Complementary MetalOxideSemiconductor Chip Technology to Detect Quantum Information in 12CQ Qubit Material at Room Temperature Archer Materials Limited announced that the Company for the first time has used complementary metaloxidesemiconductor (CMOS) chip technology to detect quantum information in the 12CQ qubit material at room temperature. Archer has now shown that quantum information in the 12CQ qubit material can be detected using: high electron mobility transistor (HEMT) technology, widely used in integrated circuits, for example in mobile phones; CMOS technology, the dominant integrated circuit technology used to make chips in the semiconductor industry. The quantum information in the 12CQ qubit material is in the form of electron `spin' states. Significant innovation is required to, firstly, design and develop on-chip devices that can detect the electron spin states in the 12CQ qubit material under practical conditions, and secondly, have these devices manufactured using standard industrial semiconductor processes. In a major technological feat, Archer has now used a single-chip integrated electron spin resonance detector based on CMOS technology to detect the quantum spin states in the as- prepared 12CQ qubit material in a controlled atmosphere at room temperature. The quantum states were found to be sufficiently well preserved when operating in the on-chip environment. The CMOS single-chip detectors: were developed by Archer collaborators at EPFL, are potentially industrially scalable, and were manufactured by Taiwan Semiconductor Manufacturing Company, apply the most widely adopted semiconductor technology used to build chips found in most modern-day devices, pave the way for implementing complex qubit control required in quantum circuits, were of sufficient sensitivity to detect the electron spin in a few picolitres (picolitre is a trillionth of a litre) of qubit material at room temperature. The signal characteristics obtained agreed with the well-studied, repeatable, and scientifically published results of measurements performed on macroscopic (bulk) quantities of the qubit material using continuous wave electron spin resonance instruments. Tillkännagivande • Sep 28
Archer Materials Limited Announces On-Chip Electronic Transport in Qubit Components Achieved Archer Materials Limited announced the Company has achieved on-chip electronic transport in qubit components at room temperature, as part of its 12CQ quantum computing qubit processor chip ("12CQ chip") technology development. This achievement is a significant technological milestone and a fundamental requirement for the operation of the 12CQ chip. During the year, the Company has made considerable progress in the design and development of the 12CQ chip, including: The detection of quantum information in the 12CQ material on-chip and at room temperature using mobile phone compatible technology. The fabrication of nanodevices that will allow probing of quantum behaviour in the 12CQ qubit material, representing the first step towards the readout of quantum states from few and single qubits. Undertaking 3D Electrostatic Finite Element Modelling in conjunction with in-house software development to simulate quantum electronic device architectures. Archer has now advanced its 12CQ quantum chip development by nanofabricating devices containing electric circuits that integrate microscopic quantities of its carbon-based qubit material. The devices were fabricated on a silicon wafer using foundry-compatible lithography processes. Archer used the devices to demonstrate that a controlled electric current can be passed through the qubit material at room-temperature. Tillkännagivande • Jul 21
Archer Materials Provides Shareholders with A Technical Progress Update on Archer's 12CQ Archer Materials provides shareholders with a technical progress update on Archer's 12CQ quantum computing chip technology (12CQ chip).To scale the fabrication of Archer's 12CQ chip devices and components, the Company will need to work with industrial-scale manufacturers in the global semiconductor supply chain. The Company must use sophisticated device modelling and simulations to determine which commercial foundries could address the Company's future fabrication. Archer has performed 3D Electrostatic Finite Element Modelling in conjunction with in-house software development relevant to the Company's qubit material. The modelling simulates quantum electronic device (QED) architectures related to qubit control and read out to obtain a precise estimate for the lower-bound on the devices' critical feature size. The complex simulations resulted in a minimum requirement for QED feature sizes that would be specifically compatible with existing standard industrial-foundry processes, including Extreme Ultra Violet Photolithography. Current quantum computing qubit architectures rely on custom made fabrication, unlike modern classical computing circuits which are primarily silicon-based and are manufactured in, and using, well-established industrial semiconductor facilities. Integrating qubit materials with complex control and readout electronics compatible with existing industrial-scale foundries is a significant challenge in developing quantum processors. Archer's 12CQ chip innovation aims to integrate its unique qubit material with mobile-compatible devices that are in a form suitable for industrial-scale semiconductor nanofabrication. Tillkännagivande • Jun 21
Archer Materials Limited Announces Fabrication of Nanodevices Towards Qubit Readout Archer Materials Limited provided shareholders with a technical progress update on Archer's 12CQ quantum computing chip technology ("12CQ chip").Archer's 12CQ quantum technology comprises a carbon nanosphere adapted to store a qubit. Control and readout devices are required to set the qubit and read the qubit stored on the carbon nanosphere. A control device is used to perform quantum operations on the qubit with a readout device measuring the results.The control and readout of Archer's electron spin-based qubit is a fundamental requirement for the future operation of the 12CQ chip. The development of complex lithography patterning methods to produce control and readout electronics compatible with scaling in a semiconductor foundry is required for the integration Archer's 12CQ chip into mobile platforms. The Company has previously announced validation of the classical behaviour of single and few- qubits and related device fabrication (e.g., ASX ann. 22 Feb. 2021), and the on-chip detection of quantum information for macroscopic quantities of qubit material using mobile compatible technology, that have direct implications on the Company's control and readout development. Archer has now successfully fabricated nanodevices that will allow probing of quantum behaviour in its qubit material that is of fundamental importance to the 12CQ chip technology operation. The nanodevice fabrication reported in this Announcement is the first step towards the readout of quantum states from few and single qubits used in Archer's 12CQ technology. Significant innovation is required to produce the nanodevices. Nanofabrication was performed using state-of-the-art lithography and specialised software, to obtain feature sizes compatible with a few to single qubits. The fabrication process is repeatable and reproducible at scale, solving challenges related to complex nanodevice proximity effects and the on-chip integration of micron and nanometre size features. Tillkännagivande • May 30
Archer Materials Limited Announces Biochip Progresses Towards Sub-10 Nanometer Fabrication Archer Materials Limited provided the shareholders with a technical progress update on the company's goal to achieve reliable fabrication of sub-10 nanometer biochip device components. In April 2021, the company announced that it had commenced nanofabrication processes with the aim of developing sub-10 nm size biochip features representing the current best-in-class in the semiconductor industry. The company recently expanded its access to state-of-art instruments and talent . It has now successfully fabricated 15 nm features reproducibly and reliably by developing and implementing several advanced lithographic processes. The achievement of 15 nm feature size represents a minimum threshold of what is required for the development of Archer's technology and paves the way to miniaturization below 10 nm. The work is a significant technical achievement as the advanced lithography semiconductor fabrication processes are complex, requiring precision engineering to reach lateral control over a feature size of 15 nm (corresponding in this work to approximately 100 atoms). Miniaturization of device components is an incremental process with each reduction in feature size requiring new and optimized lithography processes of increasing complexity. Archer has achieved miniaturization from 200 nm down to 15 nm by developing several advanced lithography processes. The extreme miniaturization would give Archer greater flexibility and higher integration density in its lithographic processes for the design and fabrication of its technology. For example, sub-10 nm fabrication could allow for biochip device development to span a magnitude of feature sizes for potential sensing applications exceeding billions of sensors, and for the fabrication of devices the size of a single, isolated qubit material (approximately 40 nm). The company is developing a biochip that would allow droplets of biological specimens to be analyzed and processed using graphene-based sensors. Archer's biochip design principles include the micro- and nanofabrication of integrated sensing devices in regions of a chip that work alongside other fabricated functional regions on the same chip to process, detect and analyze biological specimens. Advanced lithography processes performed in a semiconductor foundry are required to fabricate and integrate various features as part of a nanoelectronic device and the work done by Archer to fabricate 15 nm biochip features is an important step in the potential future operation of Archer's biochip. Tillkännagivande • Feb 01
Archer Materials Limited Provides Update on Archer's 12CQ Quantum Computing Chip Technology Archer Materials Limited provided shareholders with a technical progress update on Archer's 12CQ quantum computing chip technology ("12CQ chip"). The Company for the first time has detected quantum information in the 12CQ qubit material on-chip and at room temperature using mobile phone compatible technology. Archer and teams from EPFL have now used a single-chip integrated electron spin resonance ("ESR") detector based on a high electron mobility transistor ("HEMT") technology to detect and characterise the as-prepared 12CQ qubit material in a controlled atmosphere at room temperature. The signal characteristics obtained agreed with the well-studied, repeatable, and scientifically published results obtained from room temperature measurements performed on macroscopic (`bulk') quantities of the qubit material using continuous wave ESR instruments. The unoptimised ESR chip devices were of sufficient sensitivity to detect the electron spin in a few picolitres (picolitre is a trillionth of a litre) of qubit material at room temperature. The quantum information in the qubit material is in the form of an electron's `spin' states. The quantum states were found to be sufficiently well preserved when operating in an on-chip environment. By demonstrating the detection of electron spin quantum states using a single chip ESR detector based on HEMT, the technology paves the way for the implementation of the complex qubit control characteristics required in quantum circuits. Archer and collaborators from EPFL have used high electron mobility transistor ("HEMT") technology to detect and characterise the as-prepared 12CQ qubit material in a controlled atmosphere at room temperature. The single-chip resonator was developed at EPFL, and manufactured by semiconductor company OMMIC using existing foundry processes and facilities, near Paris, France. HEMT devices are widely used in integrated circuits, for example in mobile phones, and are well-known in the semiconductor industry due to their low power consumption (the HEMT based ESR detector chip device referred to in this Announcement consumed approximately 90 µW of power at room temperature operation). The HEMT technology was initially utilised for the ESR chip in part to confirm the advantages of low power consumption offered by a HEMT for the qubit measurements, and the chip having simplified integrated electronics to a single transistor. Archer previously showed 12CQ single qubit compatibility by integrating with silicon substrates and intends to consider silicon CMOS based ESR detectors in future development. In collaboration with EPFL, the Company for the first time has detected quantum states§ in the 12 CQ qubit material on-chip and at room temperature using mobile phone compatible technology. The coherent control of quantum information in qubit materials is the fundamental requirement for quantum logic operations that are the basis of any quantum computing qubit processor hardware. For potential development and use of Archer's qubit materials in practical quantum processor chip devices, it is significant to demonstrate the room temperature detection of quantum information using mobile-compatible device technology. The scientific breakthrough made in 2016 to realise Archer's 12CQ qubit material demonstrated the detection and manipulation of the electron spin quantum state and the deliberate and coherent electron spin rotations in a bulk quantity of the qubit material. This was direct proof validating the potential usability of the qubit material for quantum information processing applications. However, the miniaturisation of qubit materials and integration with appropriate quantum control electronics using semiconductor components to realise on-chip QIP devices is a significant challenge. Executive Departure • Nov 24
Independent Non-Executive Director Alice McCleary has left the company On the 24th of November, Alice McCleary's tenure as Independent Non-Executive Director ended after 14.8 years in the role. As of September 2021, Alice still personally held 3.87m shares (AU$6.7m worth at the time). Alice is the only executive to leave the company over the last 12 months. Reported Earnings • Sep 23
Full year 2021 earnings released: AU$0.009 loss per share (vs AU$0.014 loss in FY 2020) Full year 2021 results: Net loss: AU$3.33m (loss widened 19% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 167% per year, which means it is well ahead of earnings. Recent Insider Transactions Derivative • Jun 19
Independent Non-Executive Director exercised options to buy AU$901k worth of stock. On the 17th of June, Alice McCleary exercised options to buy 1m shares at a strike price of around AU$0.19, costing a total of AU$226k. This transaction amounted to 43% of their direct individual holding at the time of the trade. Since June 2020, Alice's direct individual holding has increased from 2.70m shares to 3.87m. Company insiders have collectively bought AU$173k more than they sold, via options and on-market transactions, in the last 12 months. Tillkännagivande • Apr 27
Archer Expands Access to Institutional Deep Tech Infrastructure Archer Materials Limited ("Archer", the "Company",) to inform shareholders that the Company has expanded its commercial access to institutional deep tech infrastructure as part of its biochip development. Archer is now directly accessing world-class analytical facilities with atom- scale quality control capabilities. The infrastructure access is necessary to carry out the Company's biochip development. Specifically, it allows Archer to qualify its semiconductor device production processes as the Company advances towards sub-10 nm biochip feature sizes. Archer is strategically securing access to local institutional deep-tech infrastructure: The successful development of Archer's biochip requires the analysis of semiconductor device materials components and the establishment of quality control processes at the nanoscale (one nanometre being a billionth of a metre). This is because Archer's biochip technology integrates materials like graphene, which is one-atom `thick' in size (i.e. a fraction of a nanometre), and device features that are nanometres in size. There are very few instruments and facilities in the world available to perform such sophisticated device and materials' analysis on precision-engineered nanoscale devices. Archer is now utilising an outstanding suite of institutional deep tech infrastructure resources to directly analyse its prototype biochips, which builds on the Company's access to a AUD 150 million research and prototype semiconductor foundry where Archer fabricates its devices. The specialist instruments and facilities that Archer newly accessed include multimillion-dollar advanced spectrometers for chemical and biological imaging at the nanoscale, and protein production facilities in laboratories. All of Archer's intellectual property rights and title to pre-existing materials are unaffected by its access to the infrastructure, facilities, and instrumentation outlined in this announcement. Reported Earnings • Feb 26
First half 2021 earnings released: AU$0.028 loss per share (vs AU$0.009 loss in 1H 2020) First half 2021 results: Net loss: AU$6.41m (loss widened 261% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has increased by 113% per year, which means it is well ahead of earnings. Tillkännagivande • Feb 22
Archer Materials Limited Achieves Electronic Transport in Single Qubit at Room Temperature, as Part of its 12CQ Quantum Computing Qubit Processor Chip Technology Development Archer Materials Limited announced the Company has achieved electronic transport in a single qubit at room temperature, as part of its 12CQ quantum computing qubit processor chip ("12CQ chip") technology development. This achievement is fundamental to the successful development of the 12CQ chip. Archer successful y performed the direct measurement of the room-temperature two-terminal resistance of the qubit material ("qubit"), which is the core component of the 12CQ chip. Current-volage traces were repeatedly and reproducibily recorded over various voltage range on single isolated qubits, two-qubits, and qubit clusters. The qubits were advantageously robust and withstood damage or change in electronic structure during measurement. The outcomes of the measurements provide the necessary quantitiative data and component-level information that directly validates the ability of the qubits to operate within the electronic parameters required for functional, gated semiconductor devices at room temperature. This represents a significant commercial advantage over competing qubit chip device proposals. Is New 90 Day High Low • Feb 22
New 90-day high: AU$1.20 The company is up 126% from its price of AU$0.53 on 24 November 2020. The Australian market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 18% over the same period. Tillkännagivande • Jan 21
Archer Materials Limited Announces the Granting of A Japanese Patent Associated to Archer's CQ Quantum Computing Chip Technology Archer Materials Limited announced the granting of a Japanese patent associated to Archer's CQ quantum computing chip technology. The JP Patent is the first granted patent protecting the CQ chip. The grant of the JP Patent represents a significant commercial milestone in Archer's development of the CQ chip. The grant of the JP Patent gives Archer access to the high-value Japanese market for the CQ chip and is the first step in the Company's efforts to access global markets. The JP Patent application successfully underwent substantive examination procedures in Japan by the Japan Patent Office. The success in the grant of the JP patent streamlines the patent granting process and procedures for the additional six international patent applications in the jurisdictions of Australia, South Korea, Hong Kong, China, Europe, and the US. The Company considers Japan as a critical strategic jurisdiction to protect and commercialise its IP. Japan is a major global economy and according to the World Economic Forum, ranks amongst the top 5 economies in the world for global competitiveness and GDP. Is New 90 Day High Low • Jan 20
New 90-day high: AU$0.76 The company is up 50% from its price of AU$0.51 on 22 October 2020. The Australian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 20% over the same period. Tillkännagivande • Dec 23
Baudin Minerals Pty Ltd signed an agreement to acquire Exploration Licenses EL 5815 and EL 5920 in Australia from Archer Materials Limited (ASX:AXE) for AUD 3.9 million. Baudin Minerals Pty Ltd signed an agreement to acquire Exploration Licenses EL 5815 and EL 5920 in Australia from Archer Materials Limited (ASX:AXE) for AUD 3.9 million on December 22, 2020. Under the agreement, Baudin Minerals Pty Ltd shall pay AUD 0.05 million upon signing of agreement, AUD 0.1 million payable if Baudin Minerals Pty Ltd elects to proceed after the end of due diligence period and balance payable in the form of cash or shares in the relevant listed entity at the election of buyer. Baudin Minerals Pty Ltd shall also pay bonus and royalty to Archer Materials Limited. Completion is subject to satisfactory due diligence, approval from South Australian Government and listing of Baudin Minerals Pty Ltd on Stock Exchange. Completion will take place on June 30, 2021 or such other date agreed by Archer Materials Limited and the Baudin Minerals Pty Ltd. The date for Completion may be extended by Baudin Minerals Pty Ltd for three months at a time (up to December 31, 2021) by paying to Archer Materials Limited AUD 0.1 million per extension (up to a total of AUD 0.2 million). Tillkännagivande • Oct 06
Archer Materials Limited Provides Patent Applications Progress Update Archer Materials Limited provided update on patent prosecution progress related to the 12CQ quantum computing qubit processor chip and graphene-based biosensor materials technology. International patent applications associated to the chip have been lodged in seven jurisdictions. These jurisdictions were selected due to the size of the economies, potential addressable markets and prevalence of key and substantial semiconductor chip manufacturing industries. The Company announced that the IPAs are progressing in various stages of National Phase jurisdictions and that all IPAs have now been published online with the most recent publication being the US application on 24 Sept 2020. Publication of the IPAs is a key step in the process for the grant of a patent. The biosensor patent application filed under the Patent Cooperation Treaty is progressing in the International Phase in the patent granting procedure, which is the first of two main phases, the second being the National Phase. The Company has taken steps to accelerate the prosecution of IPAs (chip) and its PCT application (biosensor) where possible, e.g. filing a PACE request with the European Patent Office (which may be filed only once during each stage of the procedure). Recent Insider Transactions • Oct 02
Independent Non-Executive Director recently sold AU$53k worth of stock On the 28th of September, Paul Rix sold around 100k shares on-market at roughly AU$0.53 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Tillkännagivande • Sep 28
Archer Materials Limited Appoints Ken Williams as an Independent Non-Executive Director and as A Member of the Archer Board’S Audit and Risk Management Committee Archer Materials Limited announced the appointment of Mr. Ken Williams as an independent non-executive director of Archer. Ken is currently the Independent Chairman of Statewide Super. He is also a member of Statewide Super's Investment Committee and Remuneration & Nomination Committee. Prior roles include Chair of AWE Limited, Chair of Havilah Resources Limited, Director of Queensland Cotton Limited, and Senior Finance Executive roles with Newmont Corporation, Normandy Mining, and Qantas. Ken will serve as a member of the Archer board’s Audit and Risk Management Committee. Reported Earnings • Sep 26
Full year earnings released - AU$0.014 loss per share Over the last 12 months the company has reported total losses of AU$2.80m, with losses widening by 61% from the prior year. Tillkännagivande • Aug 14
Australian Consolidated Venture Capital Pty Ltd completed the acquisition of Leigh Creek Magnesite Pty Ltd and CH Magnesite Pty Ltd from Archer Exploration Limited (ASX:AXE) for AUD 3 million. Australian Consolidated Venture Capital Pty Ltd entered into share purchase agreement to acquire Leigh Creek Magnesite Pty Ltd and CH Magnesite Pty Ltd from Archer Exploration Limited (ASX:AXE) for AUD 2.25 million on July 2, 2018. The private Australian company shall also pay bonus additional to the consideration. Under the agreement, private Australian company shall pay AUD 0.05 million as non-refundable deposit by July 16, 2018 and a further AUD 0.2 million non-refundable additional deposit by August 31, 2018 (end of due diligence period) if private Australian company elects to proceed after the end of due diligence period. Non-refundable deposit shall be part of the total consideration. The balance of the consideration shall be satisfied in cash or, if a listing has occurred, shares in the relevant listed entity (or a combination of both) at the election of private Australian company. The bonus is payable if private Australian company or a related entity of the private Australian company lists on a regulated stock exchange either before or within 6 months of completion. As of August 30, 2018, Archer Exploration Limited has received AUD 0.2 million.
Transaction is subject to satisfactory due diligence and approval from shareholders of Archer Exploration Limited. As on August 2, 2018, the Board of Directors of Archer Exploration Limited unanimously recommend that shareholders to vote in favor of the deal. As of August 30, 2018, Australian Consolidated Venture Capital Pty Ltd has completed due diligence while Archer Exploration Limited has also received third party approval. As on September 3, 2018, the shareholders of Archer Exploration Limited approved the transaction. Completion shall take place on June 30, 2018. The date for completion may be extended by private Australian company for three months at a time up to December 31, 2019 by paying to Archer Exploration Limited AUD 0.25 million per extension up to a total of AUD 0.5 million. As of August 30, 2018, both the parties agreed to extend the cutoff date from June 30, 2019 to December 31, 2019. Completion shall take place ten business days after December 31, 2019. Australian Consolidated Venture Capital Pty Ltd may extend the cutoff date by three months up to March 31, 2020 by paying AUD 0.25 million to Archer and may also elect to extend by a further three months up to June 30, 2020 by paying an additional AUD 0.25 million. As of September 5, 2018, completion will take place on December 31, 2019. As of December 30, 2019 the date of completion has been extended to June 30, 2020 by paying Archer AUD 0.5 million and this amount deducted from the final purchase price and the purchase price has increased from AUD 2 million to AUD 2.25 million. The 5% bonus payment (“Bonus”) was originally payable if the buyer achieved a stock exchange listing within 6 months of Completion. The Bonus is now payable if the buyer is listed or sells the underlying tenements at any time in the future. Archer has already received AUD 0.25 million now the company will receive AUD 2 million at completion. As of June 25, 2020, the total purchase price of the Project including AUD 0.25 million previously paid to Archer Materials Limited is approximately AUD 2.89 million plus any future bonus payments. Sequoia Financial Group Limited has been mandated by Archer Exploration Limited to assist in the deal.
Australian Consolidated Venture Capital Pty Ltd completed the acquisition of Leigh Creek Magnesite Pty Ltd and CH Magnesite Pty Ltd from Archer Exploration Limited (ASX:AXE) for AUD 3 million on August 14, 2020. AXE has received 6.54 million shares of Volatus Capital Corp. 